CN1102340A - Medicine for acne - Google Patents
Medicine for acne Download PDFInfo
- Publication number
- CN1102340A CN1102340A CN 94103869 CN94103869A CN1102340A CN 1102340 A CN1102340 A CN 1102340A CN 94103869 CN94103869 CN 94103869 CN 94103869 A CN94103869 A CN 94103869A CN 1102340 A CN1102340 A CN 1102340A
- Authority
- CN
- China
- Prior art keywords
- radix
- acne
- medicine
- flos chrysanthemi
- cortex moutan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The medicine for eliminating acne is made of 9 Chinese-medicinal materials such as chrysanthemum flower, paeonol, arnebia root, cimicifuga rhizome, etc. and features high effective rate of 95-99% after application for 10-20 days and improving pigmentation obviously after 30 days, so having beautifying function too.
Description
The invention belongs to the health medicine technical field, is a kind of component and content of eliminating the compositions of human body acne, acne.
The medicine of treatment comedo and acne as " acne Herba Senecionis Dianthui ", is made up of Chinese medicine and western medicine at present, be the external agent,, treat 20-30 days effective percentage at 70-80% according to 25 routine social surveys, the acne effective percentage at 60-80%, and there is not obvious improvement to it at pigmentation, cicatrix that face forms.
The objective of the invention is to develop that a kind of effective percentage of oral administration improves, acne Cuo scar recovery from illness back pigmentation, the medicine for acne health medicine that the new pure Chinese herbal medicine that cicatrix has clear improvement is formed.
It is considered herein that, comedo and acne is owing to reasons such as adolescence's lung-heat heat in blood, accumulated heat in gastrointestinal tract, fiery dryness accumulated in the stomach and intestine stagnate cause, the principle of effecting a permanent cure in line with curing the disease, start with from regulating the human body incretion balance, with clearing away heat and cooling blood, eliminating fire and detoxication is the rule of treatment, employing contains Chinese herb medicine components such as Flos Chrysanthemi, Cortex Moutan, Radix Arnebiae (Radix Lithospermi), Rhizoma Cimicifugae, Radix Et Rhizoma Rhei, the Radix Rehmanniae, Folium Eriobotryae, Radix Puerariae, Radix Glycyrrhizae, produces into a kind of medicine for acne.
The clean health and beauty tea of acne of this medicine for acne preparation of the present invention, on probation through 50 routine acnes (chronic acne), drink-service is used 10-20 days, and the clinical observation effective percentage is at 95-99%, takes after 30 days pigmentation, cicatrix after the face recovery from illness are improved significantly.Not only the comedo and acne therapeutic effect is significantly improved, and face is had beautification function.
Each constituent content of medicine for acne of the present invention, Flos Chrysanthemi 5-15%, Cortex Moutan 7-18%, Radix Arnebiae (Radix Lithospermi) 10-19%, Rhizoma Cimicifugae 5-22%, Radix Et Rhizoma Rhei 6-17%, Radix Rehmanniae 13-26%, Folium Eriobotryae 6-25%, Radix Puerariae 7-20%, Radix Glycyrrhizae 8-24%.
One of example formulations, Flos Chrysanthemi 15%, Cortex Moutan 7%, Radix Arnebiae (Radix Lithospermi) 19%, Rhizoma Cimicifugae 5%, Radix Et Rhizoma Rhei 6%, the Radix Rehmanniae 26%, Folium Eriobotryae 6%, Radix Puerariae 7%, Radix Glycyrrhizae 9%.
Two of example formulations, Flos Chrysanthemi 5%, Cortex Moutan 18%, Radix Arnebiae (Radix Lithospermi) 10%, Rhizoma Cimicifugae 10%, Radix Et Rhizoma Rhei 10%, the Radix Rehmanniae 13%, Folium Eriobotryae 15%, Radix Puerariae 9%, Radix Glycyrrhizae 10%.
Three of example formulations, Flos Chrysanthemi 5%, Cortex Moutan 7%, Radix Arnebiae (Radix Lithospermi) 10%, Rhizoma Cimicifugae 15%, Radix Et Rhizoma Rhei 17%, the Radix Rehmanniae 13%, Folium Eriobotryae 7%, Radix Puerariae 18%, Radix Glycyrrhizae 8%.
Four of example formulations, Flos Chrysanthemi 5%, Cortex Moutan 7%, Radix Arnebiae (Radix Lithospermi) 10%, Rhizoma Cimicifugae 22%, Radix Et Rhizoma Rhei 6%, the Radix Rehmanniae 13%, Folium Eriobotryae 6%, Radix Puerariae 20%, Radix Glycyrrhizae 11%.
Five of example formulations, Flos Chrysanthemi 5%, Cortex Moutan 7%, Radix Arnebiae (Radix Lithospermi) 10%, Rhizoma Cimicifugae 5%, Radix Et Rhizoma Rhei 6%, the Radix Rehmanniae 13%, Folium Eriobotryae 23%, Radix Puerariae 7%, Radix Glycyrrhizae 24%.
Six of example formulations, Flos Chrysanthemi 7%, Cortex Moutan 10%, Radix Arnebiae (Radix Lithospermi) 15%, Rhizoma Cimicifugae 7%, Radix Et Rhizoma Rhei 8%, the Radix Rehmanniae 13%, Folium Eriobotryae 25%, Radix Puerariae 7%, Radix Glycyrrhizae 8%.
Medicine for acne of the present invention can be drunk with the form of making tea in right amount with Folium Camelliae sinensis, can decoction, and also can make the cosmetics form and put on the skin outward.
Claims (2)
1, a kind of medicine for acne is characterized in that containing Flos Chrysanthemi, Cortex Moutan, Radix Arnebiae (Radix Lithospermi), Rhizoma Cimicifugae, Radix Et Rhizoma Rhei, the Radix Rehmanniae, Folium Eriobotryae, Radix Puerariae, Radix Glycyrrhizae component.
2, medicine for acne as claimed in claim 1 is characterized in that above-mentioned each components contents is Flos Chrysanthemi 5-15%, Cortex Moutan 7-18%, Radix Arnebiae (Radix Lithospermi) 10-19%, Rhizoma Cimicifugae 5-22%, Radix Et Rhizoma Rhei 6-17%, Radix Rehmanniae 13-26%, Folium Eriobotryae 6-25%, Radix Puerariae 7-20%, Radix Glycyrrhizae 8-24%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN94103869A CN1054748C (en) | 1994-05-10 | 1994-05-10 | Medicine for acne |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN94103869A CN1054748C (en) | 1994-05-10 | 1994-05-10 | Medicine for acne |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1102340A true CN1102340A (en) | 1995-05-10 |
CN1054748C CN1054748C (en) | 2000-07-26 |
Family
ID=5031304
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN94103869A Expired - Fee Related CN1054748C (en) | 1994-05-10 | 1994-05-10 | Medicine for acne |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1054748C (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2768343A1 (en) * | 1997-09-18 | 1999-03-19 | Oreal | Use of chrysanthemum extract to increase melanogenesis in cosmetic and pharmaceutical compositions |
US6726940B2 (en) | 1997-09-18 | 2004-04-27 | Societe L'oreal S.A. | Use of at least one extract of the genus chrysanthemum for assisting skin and/or hair pigmentation |
EP1877043A1 (en) * | 2005-05-06 | 2008-01-16 | Angiolab., Inc. | Use of paeonol for inhibiting angiogenesis or for enhancing radiosensitization |
CN101890117A (en) * | 2010-07-19 | 2010-11-24 | 伍平 | Traditional Chinese medicinal composition for treating acnes |
CN101204476B (en) * | 2007-12-12 | 2010-12-15 | 陈德顺 | Internal Chinese traditional medicine for acne |
CN103519313A (en) * | 2013-10-23 | 2014-01-22 | 桂林丰润莱生物科技有限公司 | Beautifying and acne removing drink and preparation method thereof |
CN103800583A (en) * | 2014-03-14 | 2014-05-21 | 长兴布衣药业有限公司 | Traditional Chinese medicine formulation for treating acne |
CN104998116A (en) * | 2015-08-03 | 2015-10-28 | 苏州卫生职业技术学院 | Traditional Chinese ointment for treating acne and preparation method thereof |
-
1994
- 1994-05-10 CN CN94103869A patent/CN1054748C/en not_active Expired - Fee Related
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999013856A1 (en) * | 1997-09-18 | 1999-03-25 | L'oreal | Use of at least an extract of the genus chrysanthemum for stimulating skin and/or hair pigmentation |
AU739954B2 (en) * | 1997-09-18 | 2001-10-25 | L'oreal | Use of at least an extract of the genus chrysanthemum for assisting skin and/or hair pigmentation |
US6726940B2 (en) | 1997-09-18 | 2004-04-27 | Societe L'oreal S.A. | Use of at least one extract of the genus chrysanthemum for assisting skin and/or hair pigmentation |
FR2768343A1 (en) * | 1997-09-18 | 1999-03-19 | Oreal | Use of chrysanthemum extract to increase melanogenesis in cosmetic and pharmaceutical compositions |
EP1877043A1 (en) * | 2005-05-06 | 2008-01-16 | Angiolab., Inc. | Use of paeonol for inhibiting angiogenesis or for enhancing radiosensitization |
EP1877043A4 (en) * | 2005-05-06 | 2009-06-03 | Angiolab Inc | Use of paeonol for inhibiting angiogenesis or for enhancing radiosensitization |
CN101204476B (en) * | 2007-12-12 | 2010-12-15 | 陈德顺 | Internal Chinese traditional medicine for acne |
CN101890117A (en) * | 2010-07-19 | 2010-11-24 | 伍平 | Traditional Chinese medicinal composition for treating acnes |
CN103519313A (en) * | 2013-10-23 | 2014-01-22 | 桂林丰润莱生物科技有限公司 | Beautifying and acne removing drink and preparation method thereof |
CN103519313B (en) * | 2013-10-23 | 2015-04-08 | 桂林丰润莱生物科技有限公司 | Beautifying and acne removing drink and preparation method thereof |
CN103800583A (en) * | 2014-03-14 | 2014-05-21 | 长兴布衣药业有限公司 | Traditional Chinese medicine formulation for treating acne |
CN104998116A (en) * | 2015-08-03 | 2015-10-28 | 苏州卫生职业技术学院 | Traditional Chinese ointment for treating acne and preparation method thereof |
CN104998116B (en) * | 2015-08-03 | 2018-08-24 | 苏州卫生职业技术学院 | A kind of traditional Chinese medicinal ointment and preparation method thereof for treating acne |
Also Published As
Publication number | Publication date |
---|---|
CN1054748C (en) | 2000-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1203871C (en) | Medicine for treating diseases of digestive system | |
CN1102340A (en) | Medicine for acne | |
CN1327824C (en) | Pure Chinese medicine face-beautifying face-pack | |
CN1074613A (en) | Xintai paste for heart safety | |
CN1085089C (en) | Traditional Chinese medicine for promoting blood circulation by removing blood stasis | |
CN103656122B (en) | Chinese medicine for the treatment of fever caused by exogenous pathogenic factors and preparation method thereof | |
CN1053110C (en) | Prescription of Chinese medicine for treating cholecystitis, cholelithiasis, hepatitis and cholehepatocirrhosis | |
CN1408383A (en) | Pure traditional Chinese medicine preparation for curing gastroinstestinal cancer and preparing method | |
CN102552537B (en) | Chinese medicinal composition for treating qi and blood loss | |
CN1060368C (en) | Traditional Chinese medicine Jinjiangkebao for treating cough | |
CN1047083C (en) | Pill for curing pelade | |
CN104758529A (en) | Traditional Chinese medicine composition for treating common cold due to wind-cold | |
CN1056064C (en) | Medicine for curing liver cancer and its making method | |
CN1050519C (en) | Chinese medicine granule for acne | |
CN1444954A (en) | Boneset pills | |
CN1091963A (en) | Freckle-removing beauty drug | |
CN1408384A (en) | Pure traditional Chinese medicine preparation for curing lung cancer | |
CN101284117A (en) | Stone dissolution effective prescription | |
CN104491152A (en) | Medicine used for treating alopecia areata | |
CN1058395C (en) | Inhalant for prevention and treatment of baldness | |
CN1078476C (en) | Gastric cancer treating Chinese medicine preparation | |
CN1206595A (en) | Thrombus dissolving Guiluchun | |
CN1060073C (en) | Externally used medicine bag for curing chronic pelvic infection, endometriosis, chronic cervicitis and menalgia and its making process | |
CN1207013C (en) | Pox removing liquid | |
CN1069046C (en) | Liniment for treating bony spur |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |